Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Clinical trial NCT00601926 · TERMINATED
Trial details
- NCT number
- NCT00601926
- Sponsor
- Paul Monk
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.